文献速递乳房整形与再造

乳房再造中磁共振成像兼容组织扩张器的临床结局与放疗影响

Magnetic Resonance Imaging-Conditional Tissue Expanders in Breast Reconstruction: Clinical Outcomes and Radiation Therapy Implications.
PubMed 文献 · Plast Reconstr Surg · 2025-02-11

回顾性比较2021至2024年乳房切除后即刻再造中磁共振成像兼容组织扩张器(MRI-CTE)与传统组织扩张器(TTE)的临床结局与放疗计划影响。共纳入559例患者867个扩张器,MRI-CTE组与TTE组在血清肿、移位、皮瓣坏死等结局无显著差异。MRI-CTE组放疗伪影管理需求更低,伪影直径从4 cm降至1 cm,计划靶区外放边界从20 mm减至5 mm,勾画准确性提高75%,健康组织照射减少达60%。

要点

  • MRI-CTE组与TTE组手术结局无显著差异,包括血清肿(P=0.091)、移位(P=0.827)和皮瓣坏死(P=0.251)。
  • MRI-CTE组伪影直径从4 cm降至1 cm,计划靶区外放边界从20 mm减至5 mm。
  • MRI-CTE组勾画准确性提高75%,健康组织照射减少达60%。

核心结论

  • MRI-CTE可能有助于改善临床结局,减少手术干预并提高放疗计划精确性。
  • MRI-CTE的手术结局与TTE相似,但在放疗剂量计算准确性方面更优。
  • 减少伪影调整的手动干预可降低人为错误风险,提高放疗实施的总体精确性。

研究设计与样本

  • 回顾性综述,纳入2021年至2024年接受MRI-CTE或TTE即刻乳房再造的患者。
  • 共评估559例患者的867个组织扩张器,MRI-CTE组103例患者(161个装置),TTE组456例患者(706个装置)。
  • 分析结局包括血清肿、感染、移位和扩张器丢失。

主要发现

  • MRI-CTE组与TTE组在人口学特征、手术细节和结局方面无显著差异,包括血清肿(P=0.091)、移位(P=0.827)和乳房切除皮瓣坏死(P=0.251)。
  • MRI-CTE组有3例(1.9%)需要MRI评估但无需取出扩张器。
  • MRI-CTE组放疗期间伪影管理需求更低,伪影直径从4 cm降至1 cm。
  • MRI-CTE组计划靶区外放边界从20 mm减至5 mm,勾画准确性提高75%,健康组织照射减少达60%。

临床怎么用

  • 作者认为MRI-CTE可能有助于改善临床结局,减少手术干预并提高放疗计划精确性。
  • 作者指出MRI-CTE手术结局与TTE相似,但放疗剂量计算准确性更优。
  • 作者认为减少伪影调整的手动干预可降低人为错误风险,提高放疗实施精确性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Magnetic resonance imaging-conditional tissue expanders (MRI-CTEs) were developed to address imaging artifacts and challenges in radiation planning associated with traditional tissue expanders (TTEs). This study compared the clinical outcomes and impact of radiation protocols of MRI-CTEs and TTEs in postmastectomy breast reconstruction. METHODS: A retrospective review was conducted of immediate breast reconstruction performed with MRI-CTEs or TTEs between 2021 and 2024. Outcomes, such as seroma, infection, malposition, and expander loss, were analyzed. RESULTS: A total of 867 tissue expanders were evaluated in 559 patients. The MRI-CTE cohort consisted of 103 patients (161 devices), and the TTE cohort included 456 patients (706 devices). Demographic characteristics, surgical details, and outcomes did not differ significantly, including seroma ( P = 0.091), malposition ( P = 0.827), and mastectomy skin flap necrosis ( P = 0.251). Three cases (1.9%) in the MRI-CTE cohort required MRI evaluation but did not require explantation. The MRI-CTE group had a lower need for artifact management during radiation therapy and reduced imaging artifact size from 4 cm to 1 cm in diameter. This allowed for a reduction in planning target volume margins from 20 mm to 5 mm, which improved delineation accuracy by 75% and decreased irradiation of healthy tissue by up to 60%. CONCLUSIONS: MRI-CTEs may contribute to improved clinical outcomes, with fewer surgical interventions and enhanced precision in radiation treatment planning. MRI-CTEs demonstrated surgical outcomes similar to those for TTEs, but offered improved accuracy in radiation dose calculations. Reduced manual interventions for artifact adjustment decrease the potential for human error, enhancing the overall precision of radiation treatment delivery. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Clemens MW, Mitchell MP, Christensen JM, et al. Magnetic Resonance Imaging-Conditional Tissue Expanders in Breast Reconstruction: Clinical Outcomes and Radiation Therapy Implications. Plast Reconstr Surg. 2025. PMID: 39946673. doi:10.1097/PRS.0000000000012029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。